Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Endothelin and arterial hypertension]

H Kara-Perz1, D Pupek-Musialik, T Kosicka

  • 1Klinika Chorób Wewnetrznych Instytutu Chorób Wewnetrznych Akademii Medycznej w Poznaniu.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|April 29, 1998
PubMed
Summary

Endothelins (ETs), potent vasoconstrictors, are implicated in hypertension. Therapies targeting ET receptors or synthesis show promise for treating high blood pressure.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Relationship between deficiency of vitamin D and exponents of metabolic syndrome.

European review for medical and pharmacological sciences·2015
Same author

Plasma ghrelin and interleukin-6 levels correlate with body mass index and arterial blood pressure in males with essential hypertension.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2015
Same author

The influence of antihypertensive drugs on mineral status in hypertensive patients.

European review for medical and pharmacological sciences·2014
Same author

Evaluation of insulin resistance, tumor necrosis factor alpha, and total antioxidant status in obese patients smoking cigarettes.

European review for medical and pharmacological sciences·2013
Same author

Oral L-arginine supplementation in patients with mild arterial hypertension and its effect on plasma level of asymmetric dimethylarginine, L-citruline, L-arginine and antioxidant status.

European review for medical and pharmacological sciences·2012
Same author

Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial.

Journal of endocrinological investigation·2012

Area of Science:

  • Biochemistry
  • Physiology

Background:

  • Endothelins (ETs) are peptides, including endothelin-1 (ET-1), ET-2, and ET-3, produced by various cells.
  • ETs bind to two receptor types, ET-A and ET-B, influencing blood pressure regulation.
  • ET-1 exhibits significant vasoconstrictor and mitogenic actions, suggesting a role in hypertension pathogenesis.

Discussion:

  • ETs, particularly ET-1, may contribute to hypertension through vasoconstriction and mitogenesis.
  • Infusions of synthetic ET elevate blood pressure in animals and humans.
  • Responses to ET and plasma ET-1 levels show variable alterations in hypertensive states.

Key Insights:

  • ETs play a crucial role in blood pressure regulation.
  • Hypertension may involve ET pathways, with altered responses and levels observed.
  • Interactions between ETs and other systems like the renin-angiotensin system are suggested.

Outlook:

  • Endothelin-converting enzyme inhibitors and ET receptor antagonists demonstrate potential as vasodilators.
  • Pharmacological targeting of the endothelin system offers therapeutic avenues for hypertension treatment.

Related Experiment Videos